Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
Clinical trial NCT05354557 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05354557
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2027-04-26
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.